Brief: Alembic Pharmaceuticals Ltd Announces USFDA Final Approval For Difluprednate Ophthalmic Emulsion, 0.05%
27/01/2026 07:31
Jan 27 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS: ALEMBIC PHARMACEUTICALS LTD- ANNOUNCES USFDA FINAL APPROVAL FOR DIFLUPREDNATE OPHTHALMIC EMULSION, 0.05% Source text: [ID:] Further company coverage: ALEM.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand